Communiqués AroCell AB

Actions

IDLDX

SE0003883990

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Stockholm 18:00:00 18/09/2026			Varia. 5j.	Varia. 1 janv.
0,3950 ^SEK	+1,28%		+0,51%	+11,90%

20/08	IDL Diagnostics AB (publ) publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
20/08	Calendrier du jeudi 20 août	FW

Communiqués

18/09	AroCell : Strengthening Healthcare Partnerships at SISP Indonesia 2026	PU
21/08	AroCell : IDL Diagnostics attended Diplomatic Reception hosted by the Embassy of Indonesia	PU
21/08	AroCell : Presentation of IDL Diagnostics Interim Report Q2 2026	PU
20/08	IDL Diagnostics (publ) Interim Report April 1 – June 30, 2026	AQ
18/08	AroCell : IDL Diagnostics starts partnership with Analyst Group for equity research coverage	PU
29/05	AroCell : Further strengthening partnerships in Southeast Asia	PU
20/05	AroCell : IDL Diagnostics invites to an Open House	PU
19/05	Gustav Sten appointed CEO of IDL Diagnostics	AQ
18/05	IDL Diagnostics (Q1 Review): Strong start to 2026	AQ
18/05	AroCell : Presentation of IDL Diagnostics Interim Report Q1 2026	PU
13/05	IDL Diagnostics (publ) Interim Report January 1 – March 31, 2026	AQ
22/04	IDL Diagnostics publishes the Annual Report for 2025	AQ
16/04	AroCell : Healthcare day 2026	PU
13/04	The nomination committee's proposal for the board of IDL Diagnostics for the Annual General Meeting 2026	AQ
27/03	AroCell : CACLP and meeting with new distributor	PU
20/03	AroCell : Partnership Meetings and CLIA Focus in China	PU
05/03	Anders Hultman will be stepping down as CEO of IDL Diagnostics	AQ
02/03	AroCell : Presentation of IDL Diagnostics Interim Report Q4 2025	PU
27/02	IDL Diagnostics (Q4 Review): Aims to broaden the sales model	AQ
26/02	IDL Diagnostics AB (publ) Interim Report January 1st to December 31st, 2025	AQ
20/02	AroCell : IDL Diagnostics and concile at WHX Labs Dubai	PU
05/02	IDL forms a joint venture with concile	AQ
02/02	AroCell : Meet us at WHX Labs Dubai 10-13 February	PU
02/02	AroCell : IDL Diagnostics participates at RedEye Theme Event Fight Cancer	PU
28/11	Strategy update: IDL Diagnostics	PU